Intercept Pharmaceuticals, Inc. (ICPT): Price and Financial Metrics

ICPT POWR Grades

• ICPT scores best on the Value dimension, with a Value rank ahead of 92.35% of US stocks.
• ICPT's strongest trending metric is Value; it's been moving up over the last 169 days.
• ICPT ranks lowest in Momentum; there it ranks in the 9th percentile.

ICPT Stock Summary

• The capital turnover (annual revenue relative to shareholder's equity) for ICPT is -2.27 -- better than merely 3.04% of US stocks.
• Equity multiplier, or assets relative to shareholders' equity, comes in at -2.96 for Intercept Pharmaceuticals Inc; that's greater than it is for only 3.16% of US stocks.
• Over the past twelve months, ICPT has reported earnings growth of -79.55%, putting it ahead of just 21.48% of US stocks in our set.
• Stocks that are quantitatively similar to ICPT, based on their financial statements, market capitalization, and price volatility, are KPTI, BNFT, TMDX, RDUS, and RMED.
• ICPT's SEC filings can be seen here. And to visit Intercept Pharmaceuticals Inc's official web site, go to www.interceptpharma.com.

ICPT Valuation Summary

• ICPT's price/sales ratio is 1.5; this is 60.53% lower than that of the median Healthcare stock.
• ICPT's price/sales ratio has moved down 98.5 over the prior 108 months.
• ICPT's EV/EBIT ratio has moved up 12.1 over the prior 108 months.

Below are key valuation metrics over time for ICPT.

ICPT Growth Metrics

Its year over year net income to common stockholders growth rate is now at 36%.
• The 5 year price growth rate now stands at -35.89%.
• Its 5 year cash and equivalents growth rate is now at -5.66%.

Over the past 15 months, ICPT's revenue has gone up $70,981,000.

The table below shows ICPT's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-09-30	354.332	-61.467	-107.293
2021-06-30	341.026	-106.584	-170.13
2021-03-31	321.699	-125.945	-222.317
2020-12-31	312.69	-170.026	-274.88
2020-09-30	300.922	-214.535	-320.891
2020-06-30	283.351	-220.813	-339.255

ICPT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ICPT has a Quality Grade of B, ranking ahead of 77.14% of graded US stocks.
• ICPT's asset turnover comes in at 0.66 -- ranking 47th of 682 Pharmaceutical Products stocks.
• GBT, AVDL, and SYRS are the stocks whose asset turnover ratios are most correlated with ICPT.

The table below shows ICPT's key quality metrics over time.